title: Improving thrombolysis for acute ischemic stroke in Lombardia stroke centers.
abstract: The purpose of this study is to identify which factors are able to limit or hamper the access to systemic thrombolysis (evTPA) in Lombardia to define corrective interventions. We analyzed 1,015 patients with ischemic stroke admitted to emergency departments (ED) participating to the Lombardia Stroke Unit Registry and eligible for evTPA; 303 (29.9%) patients were treated with evTPA (evTPA+ group) and 712 (70.1%) were not (evTPA- group). We collected case-mix and stroke care process variables.The evTPA+ group was characterized by a shorter ED arrival time, a greater neurological impairment, a more chance to be admitted to ED linked to comprehensive stroke center (CSC) and a shorter waiting time to access to diagnostic procedures. The chance to be treated with evTPA was greater if neurological evaluation anticipated neuroimaging (p = 0.0003). The multivariate analysis confirmed that the admission to ED linked to CSC (OR: 2.50, 95% CI: 1.39-4.48, p < 0.0001) and neurological evaluation performed before neuroimaging (OR: 2.34, 95% CI: 1.35-4.04, p = 0.002) increased the probability to receive rtPA. The evTPA treatment is strictly dependent on pre-hospital and ED care process phases and strongly influenced by the degree of stroke severity. Door-to-needle time is shorter in patients with a greater stroke severity and a shorter ED arrival time. A 24-h/week availability of the neurologist in ED can increase the percentage of thrombolysis optimizing the selection of patients and the timing of the diagnostic procedures.
authors: Dipartimento di Neurologia d'Urgenza e Pronto Soccorso, IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino, Pavia, Italy, anna.cavallini@mondino.it
authors: A
authors: A
authors: Cavallini
authors: E
authors: E
authors: Tartara
authors: S
authors: S
authors: Marcheselli
authors: E
authors: E
authors: Agostoni
authors: S
authors: S
authors: Quaglini
authors: G
authors: G
authors: Micieli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D003953:Diagnosis-Related Groups; D004636:Emergency Service, Hospital / Q000639:trends*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D020379:Risk Adjustment; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015912:Thrombolytic Therapy / Q000379:methods / Q000639:trends*; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents
references: Int J Stroke. 2009 Jun;4(3):187-99
references: 19659821
references: Cerebrovasc Dis. 2011;31(1):37-42
references: 20980752
references: Stroke. 2011 Sep;42(9):2651-65
references: 21868727
references: Circulation. 2010 Nov 2;122(18 Suppl 3):S818-28
references: 20956227
references: Arch Neurol. 1989 Jun;46(6):660-2
references: 2730378
references: Stroke. 1992 Mar;23(3):438
references: 1610453
references: Neurol Sci. 2010 Oct;31(5):555-64
references: 20339888
references: Stroke. 2002 May;33(5):1301-7
references: 11988607
references: Stroke. 2011 Oct;42(10):2838-43
references: 21852612
references: Stroke. 2005 Jul;36(7):1597-616
references: 15961715
references: Cerebrovasc Dis. 2009;27(6):594-8
references: 19390186
references: Age Ageing. 2004 Mar;33(2):116-21
references: 14960425
references: N Engl J Med. 2008 Sep 25;359(13):1317-29
references: 18815396
references: Arch Neurol. 2008 Aug;65(8):1041-3
references: 18695054
references: Curr Opin Neurol. 2012 Feb;25(1):5-10
references: 22157105
references: Stroke. 2008 Mar;39(3):924-8
references: 18239184
references: Circ Cardiovasc Qual Outcomes. 2012 May;5(3):314-20
references: 22534407
references: Stroke. 2005 Jun;36(6):1232-40
references: 15890989
references: J Stroke Cerebrovasc Dis. 2013 Jan;22(1):49-54
references: 21852156
references: JAMA. 2000 Jun 21;283(23):3102-9
references: 10865305
references: J Stroke Cerebrovasc Dis. 2010 Mar;19(2):116-20
references: 20189087
references: Lancet Neurol. 2006 Mar;5(3):279-82
references: 16488384
references: Stroke. 1999 Jan;30(1):40-8
references: 9880386
references: Cerebrovasc Dis. 2011;31(3):278-83
references: 21178353
references: Stroke. 2011 Sep;42(9):2492-7
references: 21799155
references: Ann Emerg Med. 1999 Apr;33(4):373-8
references: 10092713
references: Circulation. 2007 May 22;115(20):e478-534
references: 17515473
references: Stroke. 2011 Oct;42(10):2983-9
references: 21885841
references: Lancet. 2007 Jan 27;369(9558):299-305
references: 17258670
references: J Stroke Cerebrovasc Dis. 2013 May;22(4):349-57
references: 22051352